ALPHA 1-ANTITRYPSIN - ANVISA Registration 82890930002

Access comprehensive regulatory information for ALPHA 1-ANTITRYPSIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82890930002 and manufactured by R-BIOPHARM AG. The registration is held by R-BIOPHARM BRASIL COMERCIO DE PRODUTOS PARA ANALISE DE ALIMENTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DIAGAM S.A., BECKMAN COULTER INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.